AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/10/2026

1. SION
2. SPY
3. NVDA
4. RKLB
5. CSQR
6. B
7. MNDY
8. ACH
9. SLN
10. NTHI

Go back to AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program
AbbVie (NYSE: ABBV) Delayed: 247.97 +1.93 (0.78%)
Previous Close $246.04    52 Week High $68.12 
Open $245.65    52 Week Low $50.71 
Day High $248.01    P/E 53.79 
Day Low $244.03    EPS $4.61 
Volume 3,838,746